Method Article

Characterization of Genetically Engineered Mesenchymal Stem Cells for Neurotherapeutic Applications

August 7th, 2025

In This Article

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Source: Sharma, A. D., et.al. High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies. J. Vis. Exp. (2015)

This video demonstrates the process of characterizing transgenic mesenchymal stem cells engineered to express therapeutic neurotrophic factors. It outlines the steps involved in fixing, permeabilizing, and staining the cells with primary and secondary antibodies targeting a cell proliferation marker, followed by analysis using a high-content screening system to capture fluorescent signals in the nuclei. Increased proliferation marker expression confirms the suitability of the transgenic cells for neurotherapeutic applications.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All procedures involving animal samples have been reviewed and approved by the appropriate animal ethical review committee.

1. Ki67 Cell Proliferation Assay

  1. Ki67 Cell Proliferation Assay (Immunocytochemistry)
    1. Rinse the cell cultures with 0.1 M phosphate (PO4) buffer for one minute two times. Fix the culture with 4% paraformaldehyde (PFA) for 20 min at room temperature. Remove the PFA and rinse the wells with PBS for seven minutes three times.
    2. After the final rinse, add 100 µl of blocker solution (phosphate buffer saline, 5% normal donkey serum, 0.4% bovine albumin serum, and 0.2% Triton X-100) to each well and incubate at room temperature for 1 hr. Prepare the primary antibody, rabbit anti-Ki67, by diluting in blocker solution at a working ratio of 1:200.
    3. Remove the blocker solution and apply 100 µl of the primary antibody solution to each well. Cover the 96-well plate and incubate the samples at 4 °C overnight.
    4. On the following day, remove the antibody solution and rinse with PBS for 7 min, 3 times.
    5. Prepare the secondary antibody, donkey anti-rabbit Cy3 in blocking solution at a working ratio of 1:500. Add DAPI nuclear stain to the secondary antibody solution at a dilution of 1:100. After the removal of the last PBS rinse, apply 100 µl of the secondary antibody/DAPI solution to each well. Incubate at room temperature in the dark for 90 min.
    6. Remove the secondary antibody/DAPI solution and rinse each well with PBS for 7 min, 3 times. Cover the 96-well plate and store at 4 °C until imaging.

2. Automated Imaging and Multiwavelength Scoring Analysis

  1. Load a 96-well plate (previously processed for Ki67 immunolabeling) into the HCS system and allow the plate to equilibrate for 20 min. Open the HCS system image acquisition and analysis software.
  2. Choose the acquisition settings for the 10X objective using camera binning at 1 and a gain setting of 2. Find the Z-plane in which the cells reside by utilizing the Auto Exposure function and calculate the offset for each wavelength of interest. For this analysis, capture images for DAPI (W1), Cy3 (W2). Choose the maximum intensity level at which the negative control wells show no signal for image acquisition. Confirm this setting is appropriate for the positive wells.
  3. Acquire plate. Capture images and store them in the image acquisition and analysis software’s database.
  4. Once images have been acquired, open image acquisition and analysis offline software and review plate data from the images acquired above.
  5. Select the Multi-wavelength scoring analysis. Configure the minimum and maximum intensities for each wavelength.
    NOTE: DAPI detection should mark the staining around each visible nucleus. Cy3 should detect the positive cells with Ki67 immunoreactivity (IR) and should not detect IR under the negative controls. For Cy3 Ki67 IR, the approximate minimum width was 7 µm, approximate maximum width was 30 µm, the intensity above the local background was 150 gray levels, and the minimum stained area was 50 µm2.
  6. Run analysis for all positions. Export the data to view in spreadsheet.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
96 well platesGreiner Bio One65509096 well plates selected for use in ImageXpress
Bovine serum albumin (BSA)Sigma-Aldrich (St. Louis, MO)A9647
Rabbit anti-Ki67 antibodyAbcam (Cambridge, MA)Ab166671:200 dilution
DAPIInvitrogen (Carlsbad, CA)D3571
Donkey anti-Rabbit Cy3Jackson Immuno Res Lab (West Grove, PA)711-165-1521:500 dilution
Mouse MSCs of adult C57BL/6 miceTulane Cent for Gene Therapy (New Orleans, LA) Isolated from bone marrow
Genetically modified MSCs (GFP, BDNF, GDNF, BDNF/GDNF)These cells were obtained from our previous study : Ye et. al. (in preparation)
Normal donkey serum (NDS)Jackson Immuno Res Lab (West Grove, PA)017-000-121
Paraformaldehyde (PFA)Fisher Scientific (Hampton, NH)O40424% PFA in 0.1M PO4 buffer
Phosphate buffered saline (PBS)Sigma-Aldrich (St. Louis, MO)P4417
Triton X-100Sigma-Aldrich (St. Louis, MO)X100
ImageXpress MicroMolecular devices (Sunnyvale, CA)ImageXpress microHigh content screening system
MetaXpress 4.0Molecular devices (Sunnyvale, CA)MetaXpress 4.0Image acquisition and analysis software
KH₂PO₄Fisher Scientific (Hampton, NH)P285For PO₄ buffer
K₂HPO₄Fisher Scientific (Hampton, NH)P288For PO₄ buffer

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Mesenchymal Stem CellsNeurotrophic FactorsCell Proliferation AssayHigh Content ScreeningImmunofluorescence StainingKi 67 MarkerGFP ExpressionParaformaldehyde FixationSecondary AntibodiesDNA Binding Dye

Related Articles